- Tamarixetin
-
- $83.00
-
2026-07-27
- CAS:603-61-2
- Purity: 98.76%
- Supply Ability: 10g
- Tamarixetin
-
-
2023-02-24
- CAS:603-61-2
- Min. Order: 5mg
- Purity: ≥98%(HPLC)
- Supply Ability: 10 g
- TAMARIXETIN
-
- $1.00
-
2019-07-06
- CAS:603-61-2
- Min. Order: 1g
- Purity: 99%
- Supply Ability: 100KG
|
| | TAMARIXETIN Basic information |
| Product Name: | TAMARIXETIN | | Synonyms: | 3,3',5,7 TETRAHYDROXY-4'-METHOXYFLAVONE;TAMARIXETIN;QUERCETIN-4'-METHYL ETHER;3,3’,5,7-tetrahydroxy-4’-methoxy-flavon;QUERCETIN-4''-METHYL ETHER hplc;3,5,7-Trihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one;Chiosmethin;4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(3-hydroxy-4-methoxyphenyl)- | | CAS: | 603-61-2 | | MF: | C16H12O7 | | MW: | 316.26 | | EINECS: | 210-050-7 | | Product Categories: | Aromatics;Heterocycles;Intermediates & Fine Chemicals;Metabolites & Impurities;Pharmaceuticals;Flavanols | | Mol File: | 603-61-2.mol |  |
| | TAMARIXETIN Chemical Properties |
| Melting point | 265-268°C | | Boiling point | 601.8±55.0 °C(Predicted) | | density | 1.634±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO: Slightly Soluble; Methanol: Slightly Soluble | | form | A solid | | pka | 6.31±0.40(Predicted) | | color | Yellow to brown | | InChI | 1S/C16H12O7/c1-22-11-3-2-7(4-9(11)18)16-15(21)14(20)13-10(19)5-8(17)6-12(13)23-16/h2-6,17-19,21H,1H3 | | InChIKey | FPLMIPQZHHQWHN-UHFFFAOYSA-N | | SMILES | [o]1c2c([c](c(c1c3cc(c(cc3)OC)O)O)=O)c(cc(c2)O)O | | LogP | 2.420 (est) |
| Risk Statements | 22 | | Safety Statements | 22-45 | | WGK Germany | WGK 3 | | Storage Class | 11 - Combustible Solids |
| | TAMARIXETIN Usage And Synthesis |
| Description | 4''-O-methyl Quercetin is a flavonoid isolated from C. ordata with anticancer and antiplasmodial activity. 4''-O-methyl Quercetin is a major metabolite of quercetin (Item No. 10005169) that inhibits the viability of HL-60, U937, MOLT-3, Raji, K562, MCF-7, SK-MEL-1, and A549 human tumor cell lines with IC50 values ranging from 5.5-24.1 μM. It induces G2-M arrest and inhibits tubulin polymerization in vitro in a dose-dependent manner. 4''-O-methyl Quercetin inhibits breast cancer resistance protein (BCRP/ABCG2; IC50 = 40 nM in a vesicular transport assay) with no cellular toxicity indicating potential for use in overcoming multidrug resistance in chemotherapy. 4''-O-methyl Quercetin also reduces in vitro proliferation of chloroquine-resistant P. falciparum (IC50 = 4.8 μM) and suppresses infection in mice (65-81% suppression at 2.5-5 mg/kg dose). | | Uses | A major metabolite of the flavanoid Quercetin (Q509500) with antioxidant properties. It helps to protect H9c2 cardiomyoblasts against H2O2-induced oxidative stress via the modulation of PI3K/Akt and ERK1/2 signaling pathways. | | Definition | ChEBI: A monomethoxyflavone that is quercetin methylated at position O-4'. Isolated from Cyperus teneriffae. | | General Description | This substance is a primary reference substance with assigned absolute purity (considering chromatographic purity, water, residual solvents, inorganic impurities). The exact value can be found on the certificate. Produced by PhytoLab GmbH & Co. KG | | in vivo | Tamarixetin (0.2% feed management; 6 weeks) improves the myocardial hypertrophy model [2].
Tamarixetin (intraperitoneal injection; 1 mg/kg; single dose) has better anti-inflammatory properties, which is related to the increase of the immune cell population secreting IL-10 in mouse models of bacterial septicemia[3]. | Animal Model: | Transverse aortic constriction (TAC) mouse model[2] | | Dosage: | 0.2% | | Administration: | Feed management; 6 weeks | | Result: | Alleviated pressureoverloadinduced cardiac hypertrophy in mice.
Attenuated cardiac fibrosis and apoptosis in pressureoverloaded hearts.
Suppressed oxidative stress.
Negatively regulated NFAT nuclear translocation level.
Was able to the down-regulate the activation of PI3K/AKT signaling pathway in the heart after pressure overload.
|
| | References | [1] FABIO NICOLINI. Induction of G2/M phase arrest and apoptosis by the flavonoid tamarixetin on human leukemia cells.[J]. Molecular Carcinogenesis, 2014, 53 12: 939-950. DOI: 10.1002/mc.22055
[2] KEE W. TAN . Identification of novel dietary phytochemicals inhibiting the efflux transporter breast cancer resistance protein (BCRP/ABCG2)[J]. Food Chemistry, 2013, 138 4: Pages 2267-2274. DOI: 10.1016/j.foodchem.2012.12.021
[3] I C EZENYI. Antiplasmodial activity-aided isolation and identification of quercetin-4’-methyl ether in Chromolaena odorata leaf fraction with high activity against chloroquine-resistant Plasmodium falciparum.[J]. Parasitology Research, 2014, 113 12: 4415-4422. DOI: 10.1007/s00436-014-4119-y |
| | TAMARIXETIN Preparation Products And Raw materials |
|